Aflac Incorporated (NYSE:AFL) declared a quarterly dividend on Tuesday, October 27th, RTT News reports. Investors of record on Wednesday, November 18th will be paid a dividend of 0.28 per share by the financial services provider on Tuesday, December 1st. This represents a $1.12 annualized dividend and a yield of 2.70%. The ex-dividend date is Tuesday, November 17th.
Aflac has a payout ratio of 24.0% meaning its dividend is sufficiently covered by earnings. Research analysts expect Aflac to earn $4.83 per share next year, which means the company should continue to be able to cover its $1.12 annual dividend with an expected future payout ratio of 23.2%.
Shares of AFL stock opened at $41.52 on Monday. The stock has a 50 day moving average of $36.99 and a 200 day moving average of $36.56. The company has a current ratio of 0.06, a quick ratio of 0.06 and a debt-to-equity ratio of 0.24. The stock has a market cap of $28.32 billion, a P/E ratio of 6.49, a P/E/G ratio of 1.64 and a beta of 0.81. Aflac has a twelve month low of $23.07 and a twelve month high of $55.07.
In other news, Director Charles D. Lake II sold 16,392 shares of Aflac stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $37.32, for a total value of $611,749.44. Following the sale, the director now directly owns 83,540 shares of the company’s stock, valued at $3,117,712.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.40% of the company’s stock.
AFL has been the subject of several recent research reports. ValuEngine cut Aflac from a “sell” rating to a “strong sell” rating in a research report on Monday, August 3rd. TheStreet upgraded Aflac from a “c+” rating to a “b-” rating in a research report on Wednesday, October 7th. SunTrust Banks cut their price objective on Aflac from $44.00 to $37.00 and set a “hold” rating for the company in a research report on Thursday, July 30th. Credit Suisse Group boosted their price objective on Aflac from $35.00 to $40.00 and gave the company a “neutral” rating in a research report on Tuesday, September 22nd. Finally, Morgan Stanley boosted their price objective on Aflac from $45.00 to $46.00 and gave the company an “equal weight” rating in a research report on Tuesday, October 6th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and an average price target of $43.25.
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, income support, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products.
Further Reading: How interest rates affect municipal bond prices
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.